Global Stress Tests Equipment Market is valued at approximately USD 2.25 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2029. Stress Tests Equipment is a measurement of determining the heart operating efficiency of a patient working under stressful and normal conditions. Stress tests enable a physician or healthcare provider to identify anomalies such as lack of oxygen to the heart and blood flow in stressful conditions. The Stress Tests Equipment market is expanding because of factors such as growing aged population and growing awareness about various cardiac and respiratory diseases.

According to Statista, in May 2022 a survey conducted by Rakuten Insight in India, 50 percent of respondents in the 24 - 34 age group stated that they were feeling more stressed or anxious during past 12 months. In the same survey, 28 percent of respondents in the 16 - 24 age group stated that they experienced the same level of stress and anxiety as before. According to Statista, the prevalence of heart disease in the United States between 1997 and 2019, decreased from 20.8 percent to 18.3 percent. Moreover, Globally, about 25 percent of the world is under 15 years of age and 10 percent is over 65 years of age. Meanwhile, Africa has the youngest population worldwide, nearly 40 percent of the population is below 15 years, and less than four percent is above 65, indicating the low life expectancy in several of the countries. In Europe, on the other hand, a higher number of the population is above 65 years than the population under 15 years. However, lack of uniformity in reimbursement for stress test equipment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Stress Tests Equipment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the growing awareness about various cardiac and respiratory diseases. According to Statista, in 2020, In Canada 191 number of patients out of 100,000 died due to major cardiovascular diseases. furthermore , Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such rising levels of air pollution that have increased the occurrence of both respiratory and cardiovascular issues in the market space.

Major market players included in this report are:

Thermo Fisher Scientific Ltd
Philips Healthcare
Cardinal Health
Care Medical Ltd
Cosmed Medical
Cardiac Science Corporation
GE Healthcare
custo med GmbH
Mortara Instrument, Inc
MGC Diagnostics Corporation

Recent Developments in the Market:
? In Oct 2022 GE Healthcare introduces its new PET/CT platform named Omni Legend. This state-of-the-art device utilizes a new category of digital BGO detector material with a small crystal size that offers more than twice the sensitivity of earlier digital scanners, enabling shorter total scan times and outstanding minor lesion detectability. It is designed to boost diagnostic power, improve operating efficiency, and patient experience.

? In Nov 2022 CAIRE Inc acquired MGC Diagnostics Holdings, Inc. For the purpose of diagnosing, classifying, and treating cardiorespiratory disease, MGC develops and produces non-invasive diagnostic systems, consumables, and accessories.

Global Stress Tests Equipment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Cardiopulmonary Exercise Testing System
Stress ECG
Pulse Oximeters
Stress Blood Pressure Monitors
Others

By Application:
Hospitals
Specialty Clinics/Cardiology Clinics
Ambulatory Surgical Centers
Diagnostic Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World